Martin Hoffman, DO
Gastroenterology · Hartford, CTNPI 1922035617
Payments from drug & device makers
Across 715 payments — averaging $442.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$136K
- Capsovision, Inc.$89K
- AbbVie$44K
- Madrigal Pharmaceuticals$41K
- Intercept Pharmaceuticals, Inc.$1K
- Bristol Myers Squibb$816
- plus $4K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 276 | $136,436 |
| Capsovision, Inc. | 23 | $89,300 |
| AbbVie | 161 | $43,716 |
| Madrigal Pharmaceuticals | 35 | $41,418 |
| Intercept Pharmaceuticals, Inc. | 11 | $1,160 |
| Bristol Myers Squibb | 39 | $816 |
| Johnson & Johnson | 34 | $641 |
| Mallinckrodt Hospital Products Inc. | 16 | $488 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $482 |
| Pfizer | 17 | $279 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $246 |
| Ipsen Biopharmaceuticals, Inc | 5 | $215 |
| Regeneron Healthcare Solutions, Inc. | 4 | $168 |
| Ferring Pharmaceuticals Inc. | 6 | $115 |
| Bayer | 4 | $94 |
| Lilly USA, LLC | 4 | $93 |
| Eisai Inc. | 1 | $92 |
| Ardelyx, Inc. | 4 | $78 |
| Sanofi | 4 | $73 |
| Celltrion USA Inc. | 4 | $70 |
| E.r. Squibb & Sons, L.L.C. | 2 | $69 |
| Medtronic | 2 | $58 |
| Fujifilm Healthcare Americas Corporation | 2 | $57 |
| Mirum Pharmaceuticals, Inc. | 2 | $56 |
| Shionogi Inc | 4 | $53 |
| Redhill Biopharma Inc. | 3 | $50 |
| AstraZeneca | 2 | $46 |
| Orphalan Inc | 2 | $44 |
| Merck | 2 | $26 |
| Ironwood Pharmaceuticals, Inc | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Exact Sciences | 1 | $22 |
| UCB, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $17 |
| Boston Scientific | 1 | $8 |
How this compares
$316,551 in reported general payments places this provider in the 95th percentile of 326 gastroenterology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Hartford
- Colin SwalesHartford$285K
- Michael EinsteinHartford$139K
- David ChaletskyHartford$49K
- Lisa RossiHartford$40K
- Pramod MistryNew Haven$6M
- Salam ZakkoBristol$2.7M
- Paul FeuerstadtHamden$1.4M
- Angelo ParedesMiddletown$1.3M
- James FrestonFarmington$778K
- Jill GaidosNew Haven$750K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.